Shapely
Shapely is a GLP-1 telehealth platform founded by Dr. Justin Zaghi, MD/MBA, a Harvard-trained physician board-certified in both internal medicine and obesity medicine.
- Semaglutide
- Not disclosed
- Tirzepatide
- Not disclosed
- Coverage
- 4 states
- Brand-name
- Yes
Line Shapely up against its closest alternatives.
Factor breakdown
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.
Strengths
- Founded by Dr. Justin Zaghi, MD/MBA — Harvard-trained, board-certified in internal medicine and obesity medicine, with Medical Director Ana Lisa
- Brand-name GLP-1s (Wegovy, Ozempic, Zepbound, Mounjaro, Foundayo) covered by major PPO and Medicare at copay
- Compounded semaglutide from $99/month with free 2-day shipping, syringes, and supplies included via 503A/503B pharmacy
- 1:1 registered dietitian (RDN) and monthly video provider visits included in every plan; unlimited chat and app support
- Cellular smart scale provided to qualifying patients for ongoing weight tracking throughout the program
What to consider
- Currently available only in California, Florida, New York, and Texas — 46 states unserved despite announced expansion
- Telehealth subscription ($99/mo self-pay, $49 first-month promo) is charged separately from compounded medication cost
- Labs not included — $75 flat rate for uninsured patients; baseline bloodwork may be required before prescribing
- No LegitScript certification found on any public page
- Compounding pharmacy partner not named publicly; 503A/503B status claimed but specific pharmacy undisclosed
Bottom line — Grade C
Best for: Shoppers who want insurance-accepted telehealth with compounded sema $99/mo and tirz $166/mo; CA, FL, NY, TX (expanding).
Site position #246 of 541. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.
Closest here
The rankings grading nearest Shapely — the realistic shortlist.
NowPatient is a US-UK telehealth platform offering brand-name GLP-1 weight management access including Mounjaro, Wegovy (injection and oral tablet), and Saxenda.
Options Medical Weight Loss offers telehealth medical weight-loss programs built around compounded GLP-1 — semaglutide starting around $239/month and tirzepatide from $299/month, plus NAD+ injections at $199/month.
Primary Clinic (Direct GLP) is a Direct Primary Care membership rather than the usual direct-to-consumer GLP-1 marketplace.
Enara Health (enarahealth.com), founded 2015 in San Mateo, CA, is a physician-led, insurance-based obesity medicine program that prescribes branded GLP-1 medications including Wegovy (semaglutide) and Zepbound (tirzepatide), alongside dietitian counseling, health coaching, metabolic testing, and behavioral support.
RestorLife Med is a physician-guided GLP-1 telehealth practice (founder Dr. Michael Wasef, MD, licensed in all 50 states) offering compounded semaglutide and tirzepatide for weight loss, including microdose entry options.
Roboclinic is an AI-first telehealth platform, operated by BrickFi, Inc., that starts you with an AI health assistant and then routes you to a board-certified provider for GLP-1 weight-loss care.
The 21 rankings nearest this one
- #250 Dr. Arevitalize65.2
- #251 Mixx Health & Wellness65.2
- #252 Southern Vitality and Weight Loss65.2
- #253 Intimate Rose65.1
- #254 Vital Edge65
- #255 BetterMe Rx64.9
- #256 Livv64.9
- #257 QuickMD64.9
- #258 Vita Bella64.9
- #259 Better U Care64.8
- #260 NEUVÉ Health64.7
- #261 Rylo Health64.7
- #262 Injectco64.6
- #263 Lumen Meds64.6
- #264 LevelUp Rx64.4
- #265 PeptidesRx64.4
- #266 Tru2u64.4
- #267 Whoosh Wellness64.4
- #268 Wisp64.4
- #269 Solaya MD64.3
- #270 AHBARx64.2
Pricing/verification reflect Shapely's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Shapely's site. Not medical advice; see our disclosure.